Advertisement

Topics

"Chimerix Announces Final Data from AdVise Trial Brincidofovir" Drugs and Medication Database

23:31 EST 20th February 2019 | BioPortfolio

Here are the most relevant "Chimerix Announces Final Data from AdVise Trial Brincidofovir" Drugs and Medications that we have found in our database.

More Information about "Chimerix Announces Final Data from AdVise Trial Brincidofovir" on BioPortfolio

We have published hundreds of Chimerix Announces Final Data from AdVise Trial Brincidofovir news stories on BioPortfolio along with dozens of Chimerix Announces Final Data from AdVise Trial Brincidofovir Clinical Trials and PubMed Articles about Chimerix Announces Final Data from AdVise Trial Brincidofovir for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chimerix Announces Final Data from AdVise Trial Brincidofovir Companies in our database. You can also find out about relevant Chimerix Announces Final Data from AdVise Trial Brincidofovir Drugs and Medications on this site too.

Showing "Chimerix Announces Final Data from AdVise Trial Brincidofovir" Drugs and Medications, all 18

Possibly Relevant

Metformin hydrochloride [state of florida doh central pharmacy]

Metformin Hydrochloride Tablets, USP

Cyclo/mag [living well pharmacy, inc.]

CYCLO/MAG KIT

Cyclo/mag 10mg/200mg [living well pharmacy, inc.]

CYCLO/MAG KIT

Synapryn [california pharmaceuticals, llc]

Synapryn 107

Dicopanol [fusion pharmaceuticals llc]

DICOPANOL

Tramapap [living well pharmacy, inc.]

Tramapap

Indium in 111 chloride [curium us llc]

Indium In 111 Chloride Sterile Solution Rx only Diagnostic - For use only in radiolabeling ProstaScint™ (Capromab Pendetide). Radioimmunotherapy - For use only in radiolabeling Zevalin™ (Ibritumomab Tiuxetan). FOR SINGLE USE ONLY

Indiclor [medi-physics inc.]

INDICLOR™

Erivedge [genentech, inc.]

These highlights do not include all the information needed to use ERIVEDGE safely and effectively. See full prescribing information for ERIVEDGE. ERIVEDGE (vismodegib) capsule for oral use Initial U.S. Approval: 2012

Gleostine [nextsource biotechnology, llc]

These highlights do not include all the information needed to use GLEOSTINE safely and effectively. See full prescribing information for GLEOSTINE. GLEOSTINE (lomustine) capsules, for oral use Initial U.S. Approval: 1976

Jevtana [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use JEVTANA safely and effectively. See full prescribing information for JEVTANA. JEVTANA (cabazitaxel) injection, for intravenous useInitial U.S. Approval: 2010

Cosmegen [recordati rare diseases, inc.]

These highlights do not include all the information needed to use COSMEGEN safely and effectively. See full prescribing information for COSMEGEN. COSMEGEN (dactinomycin for injection) for intravenous use Initial U.S. Approval: 1964

Ranitidine hydrochloride oral suspension kit [california pharmaceuticals, llc]

Ranitidine Hydrochloride Oral Suspension Pineapple/Orange Oral Suspension Kit Repackaged 70332-109

Alimta [eli lilly and company]

These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA.ALIMTA (pemetrexed for injection), for Intravenous UseInitial U.S. Approval: 2004

Dactinomycin [mylan institutional llc]

These highlights do not include all the information needed to use DACTINOMYCIN FOR INJECTION safely and effectively. See full prescribing information for DACTINOMYCIN FOR INJECTION. DACTINOMYCIN for injection, for intravenous use Initial U.S. Approval: 19

Etopophos [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use ETOPOPHOS safely and effectively. See full prescribing information for ETOPOPHOS. ETOPOPHOS(etoposide phosphate) for injection, for intravenous useInitial U.S. Approval: 1983

Paricalcitol [amneal pharmaceuticals llc]

These highlights do not include all the information needed to use PARICALCITOL CAPSULES safely and effectively. see full prescribing information for PARICALCITOL CAPSULES. PARICALCITOL capsules, for oral use.Initial U.S. Approval: 1998

Paricalcitol [bionpharma inc.]

These highlights do not include all the information needed to use PARICALCITOL CAPSULES safely and effectively. See full prescribing information for PARICALCITOL CAPSULES. PARICALCITOL capsules, for oral use Initial U.S. Approval: 1998



Advertisement
Quick Search
Advertisement
Advertisement